Partial Loss of Rpl11 in Adult Mice Recapitulates Diamond-Blackfan Anemia and Promotes Lymphomagenesis

Cell Reports

Volumn 13, Issue 4, 2015, Pages 712-722

  Morgado Palacin, Lucia ^a   Varetti, Gianluca ^a   Llanos, Susana ^a   Gómez López, Gonzalo ^a   Martinez, Dolores ^a   Serrano, Manuel ^a  

^a Structural Biology and Biocomputing Programme   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEIN P53; RIBOSOME RNA; RIBOSOME PROTEIN;

ADULT; ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLACKFAN DIAMOND ANEMIA; CANCER SUSCEPTIBILITY; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FEMALE; FETUS; GENE; GENE DELETION; LYMPHOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA PROCESSING; RPL11 GENE; ANIMAL; CELL CULTURE; ERYTHROID CELL; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ANEMIA, DIAMOND-BLACKFAN; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; ERYTHROID CELLS; LYMPHOMA; MICE; MICE, KNOCKOUT; RIBOSOMAL PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84945585250     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.09.038     Document Type: Article

References (49)

1. Acosta J.C., Ferrándiz N., Bretones G., Torrano V., Blanco R., Richard C., O'Connell B., Sedivy J., Delgado M.D., León J. Myc inhibits p27-induced erythroid differentiation of leukemia cells by repressing erythroid master genes without reversing p27-mediated cell cycle arrest. Mol. Cell. Biol. 2008, 28:7286-7295.
2. Barlow J.L., Drynan L.F., Hewett D.R., Holmes L.R., Lorenzo-Abalde S., Lane A.L., Jolin H.E., Pannell R., Middleton A.J., Wong S.H., et al. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat. Med. 2010, 16:59-66.
3. Bhat K.P., Itahana K., Jin A., Zhang Y. Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation. EMBO J. 2004, 23:2402-2412.
4. Boria I., Garelli E., Gazda H.T., Aspesi A., Quarello P., Pavesi E., Ferrante D., Meerpohl J.J., Kartal M., Da Costa L., et al. The ribosomal basis of Diamond-Blackfan Anemia: mutation and database update. Hum. Mutat. 2010, 31:1269-1279.
5. Burger K., Mühl B., Harasim T., Rohrmoser M., Malamoussi A., Orban M., Kellner M., Gruber-Eber A., Kremmer E., Hölzel M., Eick D. Chemotherapeutic drugs inhibit ribosome biogenesis at various levels. J. Biol. Chem. 2010, 285:12416-12425.
6. Bursać S., Brdovčak M.C., Pfannkuchen M., Orsolić I., Golomb L., Zhu Y., Katz C., Daftuar L., Grabušić K., Vukelić I., et al. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proc. Natl. Acad. Sci. USA 2012, 109:20467-20472.
7. Bywater M.J., Poortinga G., Sanij E., Hein N., Peck A., Cullinane C., Wall M., Cluse L., Drygin D., Anderes K., et al. Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell 2012, 22:51-65.
8. Caldarola S., De Stefano M.C., Amaldi F., Loreni F. Synthesis and function of ribosomal proteins--fading models and new perspectives. FEBS J. 2009, 276:3199-3210.
9. Challagundla K.B., Sun X.-X., Zhang X., DeVine T., Zhang Q., Sears R.C., Dai M.-S. Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress. Mol. Cell. Biol. 2011, 31:4007-4021.
10. Cmejla R., Cmejlova J., Handrkova H., Petrak J., Petrtylova K., Mihal V., Stary J., Cerna Z., Jabali Y., Pospisilova D. Identification of mutations in the ribosomal protein L5 (RPL5) and ribosomal protein L11 (RPL11) genes in Czech patients with Diamond-Blackfan anemia. Hum. Mutat. 2009, 30:321-327.
11. Coppola J.A., Cole M.D. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature 1986, 320:760-763.
12. Dai M.-S., Arnold H., Sun X.-X., Sears R., Lu H. Inhibition of c-Myc activity by ribosomal protein L11. EMBO J. 2007, 26:3332-3345.
13. Dai M.-S., Sun X.-X., Lu H. Ribosomal protein L11 associates with c-Myc at 5 S rRNA and tRNA genes and regulates their expression. J. Biol. Chem. 2010, 285:12587-12594.
14. Danilova N., Sakamoto K.M., Lin S. Ribosomal protein L11 mutation in zebrafish leads to haematopoietic and metabolic defects. Br. J. Haematol. 2011, 152:217-228.
15. Devlin E.E., Dacosta L., Mohandas N., Elliott G., Bodine D.M. A transgenic mouse model demonstrates a dominant negative effect of a point mutation in the RPS19 gene associated with Diamond-Blackfan anemia. Blood 2010, 116:2826-2835.
16. Donati G., Peddigari S., Mercer C.A., Thomas G. 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint. Cell Rep. 2013, 4:87-98.
17. Drygin D., Lin A., Bliesath J., Ho C.B., O'Brien S.E., Proffitt C., Omori M., Haddach M., Schwaebe M.K., Siddiqui-Jain A., et al. Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. Cancer Res. 2011, 71:1418-1430.
18. Gazda H.T., Sheen M.R., Vlachos A., Choesmel V., O'Donohue M.F., Schneider H., Darras N., Hasman C., Sieff C.A., Newburger P.E., et al. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am. J. Hum. Genet. 2008, 83:769-780.
19. Ge J., Apicella M., Mills J.A., Garçon L., French D.L., Weiss M.J., Bessler M., Mason P.J. Dysregulation of the transforming growth factor β pathway in induced pluripotent stem cells generated from patients with diamond blackfan anemia. PLoS One 2015, Published online August 10, 2015. 10.1371/journal.pone.0134878.
20. Geiler C., Andrade I., Greenwald D. Exogenous c-Myc blocks differentiation and improves expansion of human erythroblasts. Int. J. Stem Cells 2014, 7:153-157.
21. Horn H.F., Vousden K.H. Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway. Oncogene 2008, 27:5774-5784.
22. Jaako P., Flygare J., Olsson K., Quere R., Ehinger M., Henson A., Ellis S., Schambach A., Baum C., Richter J., et al. Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia. Blood 2011, 118:6087-6096.
23. Keel S.B., Phelps S., Sabo K.M., O'Leary M.N., Kirn-Safran C.B., Abkowitz J.L. Establishing Rps6 hemizygous mice as a model for studying how ribosomal protein haploinsufficiency impairs erythropoiesis. Exp. Hematol. 2012, 40:290-294.
24. Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009, 10:R25.
25. Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009, 25:2078-2079. 1000 Genome Project Data Processing Subgroup.
26. Llanos S., Serrano M. Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway. Cell Cycle 2010, 9:4005-4012.
27. Lohrum M.A., Ludwig R.L., Kubbutat M.H., Hanlon M., Vousden K.H. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 2003, 3:577-587.
28. Macias E., Jin A., Deisenroth C., Bhat K., Mao H., Lindström M.S., Zhang Y. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. Cancer Cell 2010, 18:231-243.
29. McGowan K.A., Mason P.J. Animal models of Diamond Blackfan anemia. Semin. Hematol. 2011, 48:106-116.
30. McGowan K.A., Pang W.W., Bhardwaj R., Perez M.G., Pluvinage J.V., Glader B.E., Malek R., Mendrysa S.M., Weissman I.L., Park C.Y., Barsh G.S. Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome. Blood 2011, 118:3622-3633.
31. Miyake K., Utsugisawa T., Flygare J., Kiefer T., Hamaguchi I., Richter J., Karlsson S. Ribosomal protein S19 deficiency leads to reduced proliferation and increased apoptosis but does not affect terminal erythroid differentiation in a cell line model of Diamond-Blackfan anemia. Stem Cells 2008, 26:323-329.
32. Moniz H., Gastou M., Leblanc T., Hurtaud C., Crétien A., Lécluse Y., Raslova H., Larghero J., Croisille L., Faubladier M., et al. Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitro. Cell Death Dis. 2012, 3:e356. DBA Group of Société d'Hématologie et d'Immunologie Pédiatrique-SHIP.
33. Narla A., Ebert B.L. Ribosomopathies: human disorders of ribosome dysfunction. Blood 2010, 115:3196-3205.
34. Panić L., Tamarut S., Sticker-Jantscheff M., Barkić M., Solter D., Uzelac M., Grabusić K., Volarević S. Ribosomal protein S6 gene haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation. Mol. Cell. Biol. 2006, 26:8880-8891.
35. Quarello P., Garelli E., Carando A., Brusco A., Calabrese R., Dufour C., Longoni D., Misuraca A., Vinti L., Aspesi A., et al. Diamond-Blackfan anemia: genotype-phenotype correlations in Italian patients with RPL5 and RPL11 mutations. Haematologica 2010, 95:206-213.
36. Robledo S., Idol R.A., Crimmins D.L., Ladenson J.H., Mason P.J., Bessler M. The role of human ribosomal proteins in the maturation of rRNA and ribosome production. RNA 2008, 14:1918-1929.
37. Rodríguez C.I., Buchholz F., Galloway J., Sequerra R., Kasper J., Ayala R., Stewart A.F., Dymecki S.M. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet. 2000, 25:139-140.
38. Ruggero D., Shimamura A. Marrow failure: a window into ribosome biology. Blood 2014, 124:2784-2792.
39. Ruzankina Y., Pinzon-Guzman C., Asare A., Ong T., Pontano L., Cotsarelis G., Zediak V.P., Velez M., Bhandoola A., Brown E.J. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 2007, 1:113-126.
40. Sáenz Robles M.T., Symonds H., Chen J., Van Dyke T. Induction versus progression of brain tumor development: differential functions for the pRB- and p53-targeting domains of simian virus 40 T antigen. Mol. Cell. Biol. 1994, 14:2686-2698.
41. Sakai K., Miyazaki Ji. A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem. Biophys. Res. Commun. 1997, 237:318-324.
42. Sloan K.E., Bohnsack M.T., Watkins N.J. The 5S RNP couples p53 homeostasis to ribosome biogenesis and nucleolar stress. Cell Rep. 2013, 5:237-247.
43. Teng T., Thomas G., Mercer C.A. Growth control and ribosomopathies. Curr. Opin. Genet. Dev. 2013, 23:63-71.
44. Trapnell C., Roberts A., Goff L., Pertea G., Kim D., Kelley D.R., Pimentel H., Salzberg S.L., Rinn J.L., Pachter L. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 2012, 7:562-578.
45. Zhang J., Socolovsky M., Gross A.W., Lodish H.F. Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood 2003, 102:3938-3946.
46. Zhang Y., Wolf G.W., Bhat K., Jin A., Allio T., Burkhart W.A., Xiong Y. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Mol. Cell. Biol. 2003, 23:8902-8912.
47. Zhang Z., Jia H., Zhang Q., Wan Y., Zhou Y., Jia Q., Zhang W., Yuan W., Cheng T., Zhu X., Fang X. Assessment of hematopoietic failure due to Rpl11 deficiency in a zebrafish model of Diamond-Blackfan anemia by deep sequencing. BMC Genomics 2013, 14:896.
48. Zheng J., Lang Y., Zhang Q., Cui D., Sun H., Jiang L., Chen Z., Zhang R., Gao Y., Tian W., et al. Structure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activation. Genes Dev. 2015, 29:1524-1534.
49. Zhu Y., Poyurovsky M.V., Li Y., Biderman L., Stahl J., Jacq X., Prives C. Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol. Cell 2009, 35:316-326.